West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
320.88
+9.22 (2.96%)
Nov 21, 2024, 4:00 PM EST - Market closed

WST Revenue

West Pharmaceutical Services had revenue of $746.90M in the quarter ending September 30, 2024, a decrease of -0.07%. This brings the company's revenue in the last twelve months to $2.88B, down -1.71% year-over-year. In the year 2023, West Pharmaceutical Services had annual revenue of $2.95B with 2.18% growth.

Revenue (ttm)
$2.88B
Revenue Growth
-1.71%
P/S Ratio
7.94
Revenue / Employee
$271,358
Employees
10,600
Market Cap
23.24B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.95B62.90M2.18%
Dec 31, 20222.89B55.30M1.95%
Dec 31, 20212.83B684.70M31.89%
Dec 31, 20202.15B307.00M16.69%
Dec 31, 20191.84B122.50M7.13%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Koninklijke Philips 20.12B
Biogen 9.61B
Zimmer Biomet Holdings 7.60B
STERIS 5.33B
Illumina 4.39B
Mettler-Toledo International 3.76B
BioNTech SE 3.39B
BeiGene 3.35B
Revenue Rankings